Case number 1:23-cv-00689
Astellas Pharma Inc. et al v. MSN Pharmaceuticals Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 30, 2024 | 62 | ORAL ORDER: The Markman hearing scheduled for 6/13/2024 at 11:00 AM, will be held in Courtroom 2A at the J. Caleb Boggs Federal Building, 844 N. King Street, Wilmington, Delaware, before Judge Joseph F. Bataillon. Signed by Judge Joseph F. Bataillon on 05/30/2024. Associated Cases: 1:23-cv-00486-JFB-CJB, 1:23-cv-00689-JFB-CJB (AEV) (Entered: 05/30/2024) (0) |
| May 13, 2024 | 61 | STIPULATION regarding Infringement and Discovery by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 05/13/2024) (4) |
| May 13, 2024 | 60 | PROPOSED ORDER Scheduling and Consolidation Order by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 05/13/2024) (18) |
| May 10, 2024 | 59 | STIPULATION TO EXTEND TIME the deadline for the parties to submit a Joint Proposed Scheduling Order and joint letter to May 13, 2024 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 05/10/2024) (2) |
| May 7, 2024 | 58 | STIPULATION TO EXTEND TIME the deadline for the Parties to submit a Joint Proposed Scheduling Order or a joint letter to May 10, 2024 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 05/07/2024) (2) |
| May 1, 2024 | 57 | NOTICE OF SERVICE of Plaintiffs Objections and Responses to Defendants First Set of Interrogatories (No. 1) filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 05/01/2024) (2) |
| Mar 25, 2024 | 56 | NOTICE OF SERVICE of MSN's First Set of Interrogatories to Plaintiffs (No. 1) filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc..(Hitch, Cortlan) (Entered: 03/25/2024) (2) |
| Mar 13, 2024 | 55 | NOTICE OF SERVICE of MSN's Initial Invalidity Contentions regarding U.S. Patent No. 10,842,780 filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc..(Dorsney, Kenneth) (Entered: 03/13/2024) (2) |
| Mar 6, 2024 | 54 | STIPULATION TO EXTEND TIME for Defendants MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited to serve initial invalidity contentions to March 13, 2024 - filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc.. (Dorsney, Kenneth) (Entered: 03/06/2024) (1) |
| Feb 5, 2024 | 53 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Charts filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 02/05/2024) (2) |
| Jan 24, 2024 | 52 | NOTICE requesting Clerk to remove Rodney Swartz as co-counsel.. (Joyce, Alexandra) (Entered: 01/24/2024) (2) |
| Jan 17, 2024 | 51 | NOTICE OF SERVICE of MSN's Production of Physical Samples filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc..(Dorsney, Kenneth) (Entered: 01/17/2024) (2) |
| Jan 12, 2024 | 50 | STIPULATION TO EXTEND TIME for MSN to initiate shipment of bottle of tablets to January 19, 2024 - filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc.. (Dorsney, Kenneth) (Entered: 01/12/2024) (2) |
| Jan 12, 2024 | 49 | Stipulated PROTECTIVE ORDER. Signed by Judge Christopher J. Burke on 1/12/2024. (dlb) (Entered: 01/12/2024) (30) |
| Jan 11, 2024 | 48 | PROPOSED ORDER Stipulated Protective Order by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 01/11/2024) (30) |
| Jan 9, 2024 | 47 | NOTICE OF SERVICE of MSN's ANDA Production filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc..(Hitch, Cortlan) (Entered: 01/09/2024) (2) |
| Jan 9, 2024 | 46 | ORAL ORDER: The Court, having reviewed the parties' January 5, 2024 letter, (D.I. 45), hereby ORDERS that the case is STAYED pending resolution of Plaintiffs' Motion to Enforce Settlement Agreement, (D.I. 17), and limited discovery is permitted in the manner set forth in the attached order.Ordered by Judge Christopher J. Burke on 1/8/2024. (dlb) (Entered: 01/09/2024) (5) |
| Jan 5, 2024 | 45 | Joint Letter to The Honorable Christopher J. Burke from Alexandra M. Joyce, Esq. regarding Status. (Joyce, Alexandra) (Entered: 01/05/2024) (8) |
| Jan 4, 2024 | 44 | NOTICE OF SERVICE of MSN's Respones and Objections to Plaintiffs' First Set of Requests for Production (Nos. 1-4) filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc..(Hitch, Cortlan) (Entered: 01/04/2024) (2) |
| Jan 3, 2024 | 43 | Official Transcript of Case Management Conference held on 01/02/24 before Judge Christopher Burke. Court Reporter Deanna Warner, Email: deanna_warner@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/24/2024. Redacted Transcript Deadline set for 2/5/2024. Release of Transcript Restriction set for 4/2/2024. (Warner, Deanna) (Entered: 01/03/2024) (56) |
| Dec 18, 2023 | 42 | REDACTED VERSION of 40 Letter, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 12/18/2023) (4) |
| Dec 13, 2023 | 41 | REDACTED VERSION of 38 Reply Brief, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 12/13/2023) (16) |
| Dec 11, 2023 | 40 | [SEALED] Letter to The Honorable Christopher J. Burke from Daniel M. Silver regarding Plaintiffs' Reply Letter Brief in Support of their Motion to Stay Pending Resolution of Motion to Enforce Settlement Agreement - re 25 MOTION to Stay Pending Resolution of Motion to Enforce Settlement Agreement. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 12/11/2023) (0) |
| Dec 11, 2023 | 39 | STIPULATION and [Proposed] Order to File Under Seal by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 12/11/2023) (3) |
| Dec 6, 2023 | 38 | [SEALED] REPLY BRIEF re 17 MOTION to Enforce Settlement Agreement filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 12/06/2023) (0) |
| Dec 6, 2023 | 37 | STIPULATION and [Proposed] Order to File Reply Brief Under Seal by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 12/06/2023) (3) |
| Dec 6, 2023 | 36 | ORAL ORDER: The Court, having reviewed the parties' joint letter regarding a proposed scheduling order, (D.I. 33), hereby ORDERS that a scheduling conference pursuant to Fed. R. Civ. P. 16 will be held utilizing the Microsoft Teams platform on January 2, 2024 at 10:00 a.m. before Judge Christopher J. Burke. During the scheduling conference, the Court will hear argument on Plaintiffs' motion to stay, (D.I. 25), as well. By no later than December 22, 2023, the parties shall send an e-mail to the Court's Courtroom Deputy, Ms. Benyo, indicating the names and e-mail addresses of all individuals who will participate in the videoconference.. Ordered by Judge Christopher J. Burke on 12/6/2023. (dlb) (Entered: 12/06/2023) (0) |
| Dec 6, 2023 | 35 | Letter to The Honorable Christopher J. Burke from Kenneth L. Dorsney regarding MSN's Response in Objection to Plaintiffs' Motion to Stay pending resolution of Motion to Enforce Settlement Agreement - re 25 MOTION to Stay Pending Resolution of Motion to Enforce Settlement Agreement. (Dorsney, Kenneth) (Entered: 12/06/2023) (4) |
| Dec 6, 2023 | 34 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests to Defendants for the Production of Documents and Things (Nos. 1-4) filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 12/06/2023) (2) |
| Dec 5, 2023 | 33 | Joint Letter to The Honorable Christopher J. Burke from the Parties regarding [Proposed] Scheduling Order and Case Management Checklist - re 14 Oral Order,,,,,. (Attachments: # 1 Proposed Scheduling Order, # 2 Case Management Checklist)(Joyce, Alexandra) (Entered: 12/05/2023) (0) |
| Dec 5, 2023 | 32 | REDACTED VERSION of 23 Declaration by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc.. (Dorsney, Kenneth) (Entered: 12/05/2023) (30) |
| Dec 5, 2023 | 31 | REDACTED VERSION of 22 Declaration by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc.. (Dorsney, Kenneth) (Entered: 12/05/2023) (3) |
| Dec 5, 2023 | 30 | REDACTED VERSION of 21 Answering Brief in Opposition by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc.. (Dorsney, Kenneth) (Entered: 12/05/2023) (24) |
| Dec 4, 2023 | 29 | STIPULATION TO EXTEND TIME for MSN to file the redacted version of its Opposition to Plaintiffs' Motion to Enforce Settlement Agreement and related Declarations to December 5, 2023 - filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc.. (Dorsney, Kenneth) (Entered: 12/04/2023) (2) |
| Dec 1, 2023 | 28 | STIPULATION TO EXTEND TIME for Plaintiffs to file their Reply Brief In Support of their Motion to Enforce Settlement Agreement to December 6, 2023 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 12/01/2023) (2) |
| Nov 29, 2023 | 27 | ORAL ORDER: Having reviewed Plaintiffs' Motion to Stay Pending Resolution of Motion to Enforce Settlement Agreement ("Motion"), (D.I. 25), the Court hereby ORDERS as follows: (1) Within seven (7) days after the filing of Plaintiffs' Motion, Defendants', in the event they oppose the Motion, shall file a responsive letter, not to exceed five (5) single-spaced pages.; (2) Within three (3) days thereafter, Plaintiffs may file a reply letter, not to exceed two (2) single-spaced pages; and (3) By this same date, the parties may file a letter requesting a videoconference to address the Motion. Ordered by Judge Christopher J. Burke on 11/29/2023. (dlb) (Entered: 11/29/2023) (0) |
| Nov 29, 2023 | 26 | Letter to The Honorable Christopher J. Burke from Daniel M. Silver, Esq. regarding Plaintiffs' Opening Letter Brief In Support of - re 25 MOTION to Stay Pending Resolution of Motion to Enforce Settlement Agreement. (Attachments: # 1 Exhibit 1-7)(Silver, Daniel) (Entered: 11/29/2023) (0) |
| Nov 29, 2023 | 25 | MOTION to Stay Pending Resolution of Motion to Enforce Settlement Agreement - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Certification of Counsel Under Local Rule 7.1.1.)Motions referred to Christopher J. Burke.(Silver, Daniel) (Entered: 11/29/2023) (0) |
| Nov 29, 2023 | 24 | STIPULATION TO EXTEND TIME the deadline for the parties to jointly file the following: (i) a copy of the Checklist, indicating the names of Lead Counsel and Delaware Counsel for each party; (ii) a proposed Scheduling Order, which is consistent with Judge Burke's "Rule 16 Scheduling Order - Patent" (and with additional changes made to accommodate the fact that this is an ANDA litigation matter); and (iii) a letter, not to exceed three pages, that contains the following: (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order, and (c) a list of the three most significant topics (other than Scheduling Order disputes) discussed during the parties review of the Checklist items, along with a brief description as to what was discussed as to those topics to December 5, 2023 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 11/29/2023) (2) |
| Nov 27, 2023 | 23 | [SEALED] DECLARATION re 21 Answering Brief in Opposition Declaration of Bradford C. Frese by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc.. (Dorsney, Kenneth) (Entered: 11/27/2023) (0) |
| Nov 27, 2023 | 22 | [SEALED] DECLARATION re 21 Answering Brief in Opposition Declaration of Kondal Reddy Bairy by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc.. (Dorsney, Kenneth) (Entered: 11/27/2023) (0) |
| Nov 27, 2023 | 21 | [SEALED] ANSWERING BRIEF in Opposition re 17 MOTION to Enforce Settlement Agreement filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc..Reply Brief due date per Local Rules is 12/4/2023. (Dorsney, Kenneth) (Entered: 11/27/2023) (0) |
| Nov 27, 2023 | 20 | STIPULATION MSN's Stipulation to file Answering Brief in Opposition to Plaintiffs' Motion to Enforce Settlement under seal by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc.. (Hitch, Cortlan) (Entered: 11/27/2023) (3) |
| Nov 22, 2023 | 19 | REDACTED VERSION of 18 Opening Brief in Support, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 11/22/2023) (30) |
| Nov 10, 2023 | 18 | [SEALED] OPENING BRIEF in Support re 17 MOTION to Enforce Settlement Agreement filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..Answering Brief/Response due date per Local Rules is 11/27/2023. (Attachments: # 1 Exhibit A-D, # 2 Certificate of Service)(Silver, Daniel) (Entered: 11/10/2023) (0) |
| Nov 10, 2023 | 17 | MOTION to Enforce Settlement Agreement - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Certification of Counsel Under Local Rule 7.1.1.)Motions referred to Christopher J. Burke.(Silver, Daniel) (Entered: 11/10/2023) (0) |
| Nov 10, 2023 | 16 | STIPULATION and [Proposed] Order to File Under Seal by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 11/10/2023) (3) |
| Nov 9, 2023 | 15 | MOTION for Pro Hac Vice Appearance of Attorney Richard J. Berman, Attorney Janine A. Carlan, Attorney Bradford C. Frese and Attorney Julie A. Vernon - filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc.. Motions referred to Christopher J. Burke.(Dorsney, Kenneth) (Entered: 11/09/2023) (6) |
| Oct 31, 2023 | 14 | ORAL ORDER: IT IS HEREBY ORDERED that the parties shall meet and confer and discuss, in person and/or by telephone, each of the matters listed on Judge Burke's Case Management Checklist (Checklist). Within thirty (30) days from the date of this Order, the parties shall jointly file the following: (i) a copy of the Checklist, indicating the names of Lead Counsel and Delaware Counsel for each party; (ii) a proposed Scheduling Order, which is consistent with Judge Burkes "Rule 16 Scheduling Order - Patent" (and with additional changes made to accommodate the fact that this is an ANDA litigation matter); and (iii) a letter, not to exceed three pages, that contains the following: (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order, and (c) a list of the three most significant topics (other than Scheduling Order disputes) discussed during the parties review of the Checklist items, along with a brief description as to what was discussed as to those topics. Thereafter, the Court may schedule a Case Management Conference/Rule 16 Scheduling Conference to be held with Judge Burke. The Checklist and Scheduling Order can be found on Judge Burke's portion of the District Court's website. Ordered by Judge Christopher J. Burke on 10/31/2023. (dlb) (Entered: 10/31/2023) (0) |
| Oct 30, 2023 | 13 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Pharmaceuticals Private Limited for MSN Pharmaceuticals Inc. filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc.. (Dorsney, Kenneth) (Entered: 10/30/2023) (2) |
| Oct 30, 2023 | 12 | ANSWER to 1 Complaint, by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc..(Dorsney, Kenneth) (Entered: 10/30/2023) (21) |
| Aug 25, 2023 | 11 | Unopposed MOTION for Extension of Time to File Answer to Plaintiffs' Complaint - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. Motions referred to Christopher J. Burke.(Joyce, Alexandra) (Entered: 08/25/2023) (2) |
| Aug 24, 2023 | 10 | MOTION for Pro Hac Vice Appearance of Attorney Simon D. Roberts, Jason A. Leonard, Vincent Li, and Jayita Guhaniyogi - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Certifications)Motions referred to Christopher J. Burke.(Joyce, Alexandra) (Entered: 08/24/2023) (0) |
| Aug 11, 2023 | 9 | SUMMONS Returned Executed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc..MSN Pharmaceuticals Inc. served on 8/10/2023, answer due 8/31/2023. (Silver, Daniel) (Entered: 08/11/2023) (2) |
| Aug 11, 2023 | 8 | DECLARATION of Service on MSN Laboratories Pvt. Ltd. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Exhibit A-B)(Silver, Daniel) (Entered: 08/11/2023) (0) |
| Jun 29, 2023 | 7 | ORAL ORDER: Pursuant to the filing of this case, the Court issues the following order: Magistrate Judge Burke shall issue a scheduling order when appropriate. Magistrate Judge Burke shall handle all nondispositive matters on all issues, except for Daubert motions, Markman hearings, and pretrial motions in limine. The parties have the right to file an appeal of the magistrate judge's order, and the same shall be decided by the undersigned. The magistrate judge shall likewise handle all discovery matters, scheduling, and pretrial conferences. If the parties believe the magistrate judge has a conflict of interest with this case, the parties shall so notify the Court. IT IS SO ORDERED. Signed by Judge Joseph F. Bataillon on 06/29/23. (AEV) (Entered: 06/29/2023) (0) |
| Jun 28, 2023 | N/A | Case Assigned to Judge Joseph F. Bataillon of the United States District Court for the District of Nebraska, due to related cases. Please include the initials of the Judge (JFB) after the case number on all documents filed. (rjb) (Entered: 06/28/2023) (0) |
| Jun 23, 2023 | 1 | Complaint* (1) |
| Jun 23, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against MSN Laboratories Pvt. Ltd. and MSN Pharmaceuticals Inc. (Filing fee $ 402, receipt number ADEDC-4165162.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., and Astellas Pharma Global Development, Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jdb) (Entered: 06/23/2023) (Civil Cover Sheet) (2) |
| Jun 23, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against MSN Laboratories Pvt. Ltd. and MSN Pharmaceuticals Inc. (Filing fee $ 402, receipt number ADEDC-4165162.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., and Astellas Pharma Global Development, Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jdb) (Entered: 06/23/2023) (Exhibit A) (19) |
| Jun 23, 2023 | 6 | Summons Issued as to MSN Laboratories Pvt. Ltd. and MSN Pharmaceuticals Inc. on 6/23/2023. (Attachments: # 1 Summons Issued)(jdb) (Entered: 06/23/2023) (Summons Issued) (2) |
| Jun 23, 2023 | 6 | Summons Issued as to MSN Laboratories Pvt. Ltd. and MSN Pharmaceuticals Inc. on 6/23/2023. (Attachments: # 1 Summons Issued)(jdb) (Entered: 06/23/2023) (Main Document) (2) |
| Jun 23, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: Identifying Corporate Parent Astellas B.V. for Astellas Ireland Co., Ltd.; Corporate Parent Astellas US Holding Inc., for Astellas Pharma Global Development, Inc. filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. (jdb) (Entered: 06/23/2023) (2) |
| Jun 23, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,842,780. (jdb) (Entered: 06/23/2023) (1) |
| Jun 23, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 05/26/2023. Date of Expiration of Patent: 09/28/2029.Thirty Month Stay Deadline: 11/26/2025. (jdb) (Entered: 06/23/2023) (2) |
| Jun 23, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jdb) (Entered: 06/23/2023) (3) |
| Jun 23, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against MSN Laboratories Pvt. Ltd. and MSN Pharmaceuticals Inc. (Filing fee $ 402, receipt number ADEDC-4165162.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., and Astellas Pharma Global Development, Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jdb) (Entered: 06/23/2023) (Main Document) (14) |
